THE IMPACT OF ADJUNCT DAPAGLIFLOZIN ON TREATMENT SATISFACTION IN TYPE 1 DIABETES MELLITUS

被引：0
|
作者：
Gordon, J. [1 ]
Beresford-Hulme, L. [1 ]
Bennett, H. [2 ]
Tank, A. [3 ]
Edmonds, C. [3 ]
McEwan, P. [2 ]
机构：
[1] Hlth Econ & Outcomes Res Ltd, Birmingham, W Midlands, England
[2] Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales
[3] AstraZeneca, Cambridge, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB96
引用
收藏
页码：S590 / S590
页数：1
相关论文
共 50 条
  • [21] Adjunct therapies in treatment of type 1 diabetes
    Goyal, Itivrita
    Sattar, Alamgir
    Johnson, Megan
    Dandona, Paresh
    JOURNAL OF DIABETES, 2020, 12 (10) : 742 - 753
  • [22] Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
    Yadegarfar, Ghasem
    Livingston, Mark
    Cortes, Gabriela
    Alshames, Ramadan
    Leivesley, Kate
    Metters, Ann
    Horne, Linda
    Steele, Tom
    Heald, Adrian H.
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2021, 10 (02): : 132 - 136
  • [23] The Degree of Ketonemia after Dapagliflozin Treatment in Subjects with Type 2 Diabetes Mellitus
    Min, Se Hee
    Oh, Tae Jung
    Baek, Sang-Ik
    Lee, Seo Young
    Yang, Ye Seul
    Bae, Jae Hyun
    Kim, Kyoung Min
    Moon, Jae Hoon
    Choi, Sung Hee Choi
    Jang, Hak Chul
    Lim, Soo
    DIABETES, 2017, 66 : A311 - A311
  • [24] Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease
    Leiter, L.
    Cefalu, W.
    DeBruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    DIABETOLOGIA, 2012, 55 : S310 - S311
  • [25] COST-EFFECTIVENESS OF DAPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN PERU
    Elgart, J. F.
    Gonzalez, L.
    Prestes, M.
    Manrique, H.
    Solorzano, J.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2016, 19 (03) : A203 - A203
  • [26] Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)
    Nakajima, Hiroki
    Okada, Sadanori
    Mohri, Takako
    Kanda, Eiichiro
    Inaba, Naoyuki
    Hirasawa, Yoko
    Seino, Hiroaki
    Kuroda, Hisamoto
    Hiyoshi, Toru
    Niiya, Tetsuji
    Ishii, Hitoshi
    DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [27] Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)
    Hiroki Nakajima
    Sadanori Okada
    Takako Mohri
    Eiichiro Kanda
    Naoyuki Inaba
    Yoko Hirasawa
    Hiroaki Seino
    Hisamoto Kuroda
    Toru Hiyoshi
    Tetsuji Niiya
    Hitoshi Ishii
    Diabetology & Metabolic Syndrome, 10
  • [28] Treatment of diabetes mellitus type 1
    Martin, S.
    Dreyer, M.
    Kiess, W.
    Lueddeke, H. -J.
    Mueller, U. A.
    Schatz, H.
    Waldhaeusl, W.
    DIABETOLOGIE UND STOFFWECHSEL, 2007, 2 : S171 - S172
  • [29] Treatment of the Diabetes Mellitus Type 1
    Martin, S.
    Dreyer, M.
    Kiess, W.
    Lueddeke, H.-J.
    Mueller, U. A.
    Schatz, H.
    Waldhaeusl, W.
    DIABETOLOGIE UND STOFFWECHSEL, 2009, 4 : S136 - S137
  • [30] Treatment of diabetes mellitus type 1
    Martin, S.
    Dreyer, M.
    Kiess, W.
    Lueddeke, H.-J.
    Mueller, U. A.
    Schatz, H.
    Waldhaeusl, W.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 : S155 - S156
12345